Stonvex
Discover
  • Dashboard
  • World News
  • Stock News
  • Rankings
  • Surge
  • Quant Picks
  • Screener
Markets
  • Heatmap
  • Gainers & Losers
Tools
  • Compare
  • Calendar
  • Community
HomeRankingsScreenerPortfolioCommunity
Stonvex
Log inGet Started
← Back to rankings

KVUE

Live
Real-time chart · IB-grade AI research · Polygon.io data feed
Set alertSave
  • Overview
  • Financials
  • Filings
  • Short Interest
  • Ownership
  • Ratings
  • Peers
  • Options
  • News
✦
Stonvex AI

KVUE

AI Research Report

Powered by Claude

Ready to analyze KVUE

Runs the full IB-grade framework: Narrative, Reverse DCF, Comps, Sensitivity, and Deal Radar. Takes 20–40 seconds.

Free preview · 3 reports / hour · No sign-up required

Earnings

Next report date, year-over-year trend, and recent quarter history.

Earnings history activates with Polygon. When configured, this panel shows the next report date, consensus EPS/revenue, and the last 4 quarters of actual-vs-estimate.

Quant Grades

6-factor scoring with sector-relative rank. Updated daily.

Quant grades are available for tickers in our scored universe.

Financial statements

Most recent quarterly filings sourced directly from SEC EDGAR.

Financial statements activate with Polygon. The Developer plan includes quarterly and annual filings sourced directly from SEC EDGAR.

Corporate events

Share this analysis

Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.

Stonvex

AI-powered stock research for US equities.

hello@stonvex.com

Product

  • Rankings
  • Quant Picks
  • Screener
  • Markets
  • Compare
  • Calendar

Company

  • About Stonvex
  • Pricing & Plans
  • Community
  • Help & FAQ
  • Contact Us

Legal

  • Terms of Service
  • Privacy Policy
  • Privacy Consent
  • Disclaimer
  • Notices & Updates

© 2026 Stonvex. All rights reserved.

This site is for informational purposes only. Not investment advice. Past performance does not guarantee future results. Stonvex is not a registered investment advisor (RIA). You must be 18 years or older to use this service.

Latest news

Factor Grades

5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.

📅 Earnings in 28d (May 13)
Kenvue Inc

Kenvue Inc

Consumer products·NEW YORK STOCK EXCHANGE, INC.·US·IPO 2023-05-04
NEW YORK STOCK EXCHANGE, INC.Market closed
Kenvue Inc
Consumer products
—
— (—)
Open
—
Prev close
—
Day range
— – —
52W range
$14.02 – $25.17
Mkt cap
$33.31B
P/E
22.5
EPS
$0.76
Beta
0.59

Factor Grades

View details →
C+
Overall score: 55/100
B-
Valuation
C+
Growth
C+
Profitability
C-
Momentum
C+
Financial Health

Fundamentals

Valuation
Market Cap
$33.31B
P/E (TTM)
22.51S&P avg ~22
P/S (TTM)
2.19S&P avg ~2.8
P/B
3.06S&P avg ~4.5
P/FCF
19.21S&P avg ~26
EPS (TTM)
$0.76
Book/sh
$5.62
Cash/sh
$0.55
Profitability
Gross Margin
58.62%avg ~45%
Operating Margin
15.96%avg ~15%
Net Margin
9.72%avg ~12%
ROE
13.94%avg ~18%
ROA
5.46%avg ~7%
ROI
7.63%
Payout Ratio
107.55%
FCF/sh
—
Growth & Health
Rev Growth YoY
-2.14%
Rev Growth 5Y
0.89%
EPS Growth YoY
42.68%
EPS Growth 5Y
—
Current Ratio
—
Quick Ratio
0.61
Debt/Equity
—
LT Debt/Eq
—
Trading & Dividends
Beta
0.59
52W High
$25.17
52W Low
$14.02
Avg Vol (10D)
20.41M
Avg Vol (3M)
37.49M
Div Yield
4.81%
Div/sh (TTM)
—
Analyst
Sell (20)
Price Performance
5D+3.17%
MTD+0.12%
3M+1.59%
6M+10.01%
YTD+0.06%
1Y-21.08%
  • Yahoo·13h ago

    Johnson & Johnson Financial Chief Sees ‘Clear Line of Sight’ to Double-Digit Growth by 2030

    Johnson & Johnson has reinvented itself several times in recent years. Its latest earnings report signals the company has reinvented itself again. J&J posted adjusted earnings of $2.70 a share for the first quarter, narrowly beating out the $2.68 a share analysts had anticipated.

  • Yahoo·16h ago

    Johnson & Johnson Beats Earnings Estimates. Cancer Treatments Help Drive the Quarter.

    Johnson & Johnson has reinvented itself several times in recent years. J&J posted adjusted earnings of $2.70 a share for the first quarter, narrowly beating out the $2.68 a share analysts had anticipated. Sales grew by more than 11% in J&J’s Innovative Medicine arm, which includes its oncology portfolio, and 7.7% in its medical technology division.

  • Yahoo·17h ago

    Johnson & Johnson Stock Rises on Earnings Beat. These Segments Boosted the Quarter.

    Johnson & Johnson stock gained on Tuesday after the pharmaceutical giant and medical device maker posted better-than-expected earnings and flagged strong sales growth in its first quarter. J&J posted adjusted earnings of $2.70 a share for its latest quarter, narrowly beating out the $2.68 a share analysts had anticipated. For the full year, J&J is targeting adjusted earnings of $11.45 to $11.65 a share, up slightly from a prior range of $11.43 to $11.63 a share.

  • Yahoo·1d ago

    Johnson & Johnson Earnings Are Coming. Oncology Powers Growth, but Talc Lawsuits Persist.

    Johnson & Johnson has reinvented itself several times in recent years. In 2023, it spun off its consumer health division to focus on pharmaceuticals and medical devices. J&J may signal yet another iteration when first-quarter earnings are posted before the market opens Tuesday.

  • Yahoo·1d ago

    Johnson & Johnson Earnings: Oncology Powers Growth, but Talc Lawsuits Persist

    Johnson & Johnson has reinvented itself several times in recent years. In 2023, it spun off its consumer health division to focus on pharmaceuticals and medical devices. J&J may signal yet another iteration when first-quarter earnings are posted before the market opens Tuesday.

  • Yahoo·2d ago

    Jim Cramer Says “I Think at 5.25% Yield, I Want to Own Kimberly-Clark (KMB)”

    Kimberly-Clark Corporation (NASDAQ:KMB) is among the stocks Jim Cramer discussed alongside the tech market divide. When a caller inquired about the stock during the episode, Cramer said: Well… Remember, it just had that fire, the six-alarm fire at its largest distribution center of toilet paper. Let’s, you know, Mike Hsu did not necessarily set that […]

  • Yahoo·4d ago

    Newell Brands Faces Soft Core Sales: Time to Stay Cautious?

    NWL faces a tough 2026 start as tariffs pressure sales, but innovation launches and productivity savings are likely to support a gradual recovery.

  • Yahoo·6d ago

    Boomers and Retirees Are Sticking With 5 of the Highest-Yielding Dividend Kings

    Depending on who you ask, there is a chance we will get no interest rate cuts in 2026, or if we do, it’ll be just one. Inflation fueled by higher energy costs, tariffs, and a host of other factors could be the reason the Federal Reserve cites for not lowering rates until those rising costs ... Boomers and Retirees Are Sticking With 5 of the Highest-Yielding Dividend Kings

  • View all news →

Recent insider activity

View all →
  • 4OWNERSHIP DOCUMENT
    14d ago
  • 4FORM 4
    15d ago
  • 4FORM 4
    Mar 12
  • 4FORM 4
    Mar 12
  • 4FORM 4
    Mar 12